Guidance
HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation
A guide to decide on adopting single dose schedule
Authors
Languages
- English
- French: OPTIMISATION DU SCHÉMA DE VACCINATION ANTI-VPH Principales considérations en matière de prise de décision, de planification et de mise en œuvre
- Portuguese: OPTIMIZAÇÃO DO ESQUEMA DE VACINAÇÃO ANTI-VPH Principais considerações para a tomada de decisões, a programação e a implementação
- Russian: ОПТИМИЗАЦИЯ СХЕМЫ ИММУНИЗАЦИИ ПРОТИВ ВПЧ - ОСНОВНЫЕ МОМЕНТЫ, НА КОТОРЫЕ НЕОБХОДИМО ОБРАТИТЬ ВНИМАНИЕ ПРИ ПРИНЯТИИ РЕШЕНИЙ, ПЛАНИРОВАНИИ И
- Spanish: OPTIMIZACIÓN DEL ESQUEMA DE LA VACUNA CONTRA EL VPH Aspectos clave para la toma de decisiones, planificación e implementación
Publication year
2023
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- HPV
Organisations
- Clinton Health Access Initiative (CHAI)
- Gavi, the Vaccine Alliance
- Jhpiego
- John Snow, Inc (JSI)
- PATH
- United Nations Children's Fund (UNICEF)
- United States Centers for Disease Control and Prevention (US CDC)
HPV-INTRO-SINGLE
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Review of Existing Evidence on Single-Dose HPV Vaccination | Single dose consortium | 2022 | Presentation | English, French |
| HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation | PATH, JSI, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), Jhpiego, International Vaccine Access Center (IVAC), Centers for Disease Control and Prevention (CDC), John Hopkins Bloomberg School of Public Health | 2023 | Guidance | English, French, Portuguese, Russian, Spanish |
| Considerations for Human Papillomavirus (HPV) Vaccine Product Choice: Second Edition | World Health Organization (WHO) | 2024 | Guidance | English |
| The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands | HAPPI | 2025 | Report | English |
PORTFOLIO-HPV
This resource appears in the following Hot Topic page:
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| WHO position papers | World Health Organization (WHO) | Repository | Arabic, Chinese, English, French, Russian, Spanish | |
| Vaccine Detailed product profiles (DPPs) For Gavi-supported vaccines | Gavi, the Vaccine Alliance | 2022 | Repository | English, French |
| VIEW-hub data on HPV introductions, coverage, and products | International Vaccine Access Center (IVAC), Johns Hopkins University | Tool | English | |
| UNICEF Pricing Information-HPV | UNICEF | 2021 | Datasheet | English |
| HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation | PATH, JSI, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), Jhpiego, International Vaccine Access Center (IVAC), Centers for Disease Control and Prevention (CDC), John Hopkins Bloomberg School of Public Health | 2023 | Guidance | English, French, Portuguese, Russian, Spanish |
